404The page could not be found. |
404The page could not be found. |
The 12th annual meeting of the Individualizing Medicine Conference, or #CIMCON2023, will focus on direct-to-patient omics-based clinical trials while bringing together some of the world's top scientists and thought leaders to share the latest omics and data-driven technologies and research.
Check back soon for more information on speakers for #CIMCON2023 as we make updates leading up to the conference.
Professor of Computer Science,
Virginia Tech
Dr. Danfeng (Daphne) Yao is a Professor of Computer Science at Virginia Tech. She is an Elizabeth and James E. Turner Jr. '56 Faculty Fellow and CACI Faculty Fellow. Her research interests include building cyber defenses, as well as machine learning for digital health, with a shared focus on accuracy and deployment. She creates new models, algorithms, techniques, and deployment-quality tools for securing large-scale software and systems. Her patents on anomaly detection are extremely influential in the industry, cited by patents from major cybersecurity firms and technology companies. Dr. Yao is an IEEE Fellow for her contributions to enterprise data security and high-precision vulnerability screening. In 2021, she received the prestigious ACM CODASPY Lasting Research Award. She is also an ACM Distinguished Scientist. Previously, she received the NSF CAREER Award and ARO Young Investigator Award.
Assistant Professor of Biomedical Informatics, Mayo Clinic College of Medicine and Science
Associate Consultant, Biomedical Informatics
Mayo Clinic
Dr. Shulan Tian is an Associate professor of Biomedical Informatics at the Center for Individualized Medicine, Mayo Clinic, Rochester. Dr. Tian has been supporting multiple key research programs at Mayo since 2012, including Brain Specialized Programs of Research Excellence (SPORE), chronic lymphocytic leukemia (CLL) consortium, Multiple Myeloma (MM) SPORE, frontotemporal dementia (FTD) sequencing consortium and recently Tapestry DNA sequencing study.
Assistant Professor of Surgery, Mayo Clinic
College of Medicine and Science
Senior Associate Consultant I, Surgical Research
Mayo Clinic
Dr. Jae Sung is a computational biologist interested in the gut microbiome and metabolism in autoimmune disorders. He is an Assistant Professor at Mayo Clinic (Rochester, MN) in the Department of Surgery, Division of Rheumatology, and Center for Individualized Medicine’s Microbiome Program. In 2017, he joined Mayo Clinic to start his own independent biomedical data science laboratory largely aiming to advance precision medicine for patients with autoimmunity. In his free time, Jae enjoys traveling with his family, playing sports, and catching up on his favorite podcasts and periodicals.
Assistant Professor of Nursing, Mayo Clinic College of Medicine and Science
Senior Associate Consultant, Nurse Scientist
Mayo Clinic
Dr. Komal Singh is a Nurse Scientist at Mayo Clinic, AZ. Her research interest focuses on improving cancer treatment-related outcomes. She evaluates phenotypic and molecular risk factors for symptom occurrence and severity to determine underlying mechanisms so that targeted interventions can be yielded to alleviate adverse events after cancer treatment. Currently, Dr. Singh is investigating associations between chemotherapy-induced nausea and disruption in the gut microbiome composition profile in patients with breast cancer. Dr. Singh is supported for her research study with Gerstner Family Career Development Award from the Center of Individualized Medicine.
Predoctoral, Neuroscience and Regenerative Medicine
Mayo Clinic
Francis Shue is a 5th year doctoral student in the Kanekiyo lab. She is in the Neuroscience and Regenerative Medicine tracks. Her research focuses on cerebrovascular contributions to Alzheimer’s disease pathogenesis and the identification of presymptomatic cerebral spinal fluid biomarkers.
Senior Associate Consultant II, Biomedical Ethics Research Program, and the Department of
Quantitative Health Sciences
Mayo Clinic
Dr. McGowan is a Senior Associate Consultant II in the Biomedical Ethics Research Program and the Department of Quantitative Health Sciences at Mayo Clinic and a Visiting Scholar in the Department of Women’s, Gender, and Sexuality Studies at University of Cincinnati. Dr. McGowan is an empirical bioethicist whose research focuses on the ethical and social implications of technological innovations in biomedical research and clinical practice. She is currently a principal investigator of a multiple-PI National Human Genome Research Institute digital clinical trial focused on adolescent decision-making in relation to prospective genomic screening.
Section Head, Director, and Associate Professor
University of Alabama in Birmingham School of Medicine
Dr. Liz Worthey is currently an Endowed Associate Professor at the University of Alabama, Birmingham and the Director of the UAB School of Medicine Center for Computational Genomics and Data Science. She is also an Associate Director for the Hugh Kaul Precision Medicine Institute, Director of Bioinformatics for the O’Neal Comprehensive Cancer Center, Director of Bioinformatics for the UAB Pathology Molecular Diagnostics lab, and Director of the UAB GBS Genetics, Genomics, and Bioinformatics PhD theme.
Her research interests include the development and application of omic, computational biology, bioinformatic, and data science-based methods to identify and understand the impact of causal molecular variation in patients with a variety of undiagnosed, misdiagnosed, or non-definitively molecularly diagnosed diseases. These studies span rare diseases and common diseases including cancer. Her lab also focuses on the identification and study of modifier and pharmacogenomics associated variation that alters an individual’s response to therapeutics or modifies clinical presentation, progression, and/or outcome.
Professor Emeritus
Department of Ophthalmology
Mayo Clinic
Dr. John Woog has served as a consultant, Professor, and Clinical Practice Chair in the Department of Ophthalmology at the Mayo Clinic Alix School of Medicine. He has been active in medical student, resident, and fellow education in Boston, Madison, and at Mayo, and has received Teacher of the Year Awards from the Departments of Ophthalmology at Harvard Medical School and the Mayo Clinic as well as the Oliver Smith Award for Patient Care at the Tufts University School of Medicine. He has also received awards for research and leadership from the American Society of Ophthalmic Plastic and Reconstructive Surgery and Senior Achievement and Secretariat Awards from the American Academy of Ophthalmology. John has contributed over 60 articles and 30 book chapters to the medical literature and has written 3 books. Rather than speaking about eye disease today, however, John will instead be sharing a personal perspective on the potential of -omics based therapy. (script) John’s presentation was previously recorded but he will be available virtually for discussion following his talk.
Assistant Professor of Medicine and Oncology, Mayo Clinic College of Medicine and Science
Mayo Clinic Scholar
Dr. Riaz is a Mayo Clinic Scholar, BIRT NLM fellow (Biomedical Informatics and Data Science Research Training supported by a grant from the National Library of Medicine) at Harvard Medical School and a clinical informatics fellow at Mass General/Brigham Hospital. His research interests include cancer bioinformatics, digital transformation of cancer care, living evidence synthesis, and AI assisted Electronic Health Records.
Vice President, Rare Disease Translational Center
Dr. Cat Lutz is the Vice President of the Rare Disease Translational Center at The Jackson Laboratory (JAX). With 25 years of experience in mouse genetics, Dr. Lutz has focused her research efforts on patient organizations and families diagnosed with rare diseases. The JAX Rare Disease Translational Center incorporates precision mouse models and broad-based drug efficacy testing to support IND (Investigational New Drug) enabling studies. She serves as the Principal Investigator of multiple NIH sponsored programs including the Center for Precision Genetics, The Somatic Cell Genome Editing Center, and Mouse Mutant Research and Resource Center. As a neuroscientist by training, Dr. Lutz has worked on models of the central nervous system such as Spinal Muscular Atrophy, Amyotrophic Lateral Sclerosis and Friedreich’s Ataxia. She was recently awarded a 2021 Rare Impact Award by the National Organization for Rare Disorders.
As the Vice President of the Rare Disease Translational Center (RDTC) at The Jackson Laboratory (JAX), Dr Lutz works with patient-based foundations, researchers, and industry partners to roadmap therapeutic strategies for rare diseases. Her work involves the engineering of preclinical mouse models that represent patient-based mutations and the subsequent phenotyping of the mice to explore clinically relevant, translatable phenotypes. Follow-on preclinical drug safety and efficacy programs then explores therapeutics in these models that can be advanced into the clinic.
Everett J. and Jane M. Hauck Midwest Associate Director, Research and Innovation, Center for
Individualized Medicine
Associate Professor of Biomedical Informatics, Mayo Clinic College of Medicine and Science
Consultant, Research, Quantitative Health Sciences
Dr. Eric Klee is the Everett J. and Jane M. Hauck Midwest Associate Director, Research and Innovation for the Center for Individualized Medicine (CIM). In CIM, he serves as director of the Bioinformatics Core and director of Bioinformatics. He is also a Consultant in the Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, with joint appointments in the Department of Medical Genetics and in the Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology.
Associate Professor in Molecular and Human Genetics
Baylor College of Medicine
Dr. Jason Heaney is an associate professor in molecular and human genetics, genetics & genomics graduate program, and development disease models & therapeutics graduate program at Baylor College of Medicine. He is also the director of the Center for Precision Medicine Models at Baylor College of Medicine.
Dr. Heaney’s research interests include: Germ cell development and cancer, mammalian genetics, mouse models of human diseases, and genome editing technologies. Dr. Heaney’s laboratory use mouse genetics, genomics and genome editing technologies to catalog gene function and contribution to human disease. Ongoing research includes: Characterizing genes and developmental pathways that contribute to testicular germ cell tumors (TGCTs), identifying the function of protein-coding genes in the mouse genome, developing and employing reporter mouse strains to evaluate new genome editing delivery systems, and characterizing gene and variant contribution to Mendelian diseases.
William O. Lund, Jr. and Natalie C. Lund Program Director for Clinomics, Center for Individualized
Medicine
Professor of Anesthesiology and Assistant Professor of Physiology, Mayo Clinic College of Medicine
and Science Mayo Clinic
Consultant, Anesthesiology and Perioperative Medicine
Mayo Clinic
Dr. Timothy Curry is the William O. Lund, Jr. and Natalie C. Lund Program Director for Clinomics, Center for Individualized Medicine, he is also the Midwest associate director for Clinical Implementation Medicine, Center for Individualized Medicine, and the Co-director of the Clinomics Program, Center for Individualized Medicine. Outside of CIM he is the Vice chair for clinical practice in the Department of Anesthesiology and Perioperative Medicine at Mayo Clinic.
Chief Scientific Officer, Real World Evidence
Executive Director, Data Analytics
Clinical Trial Services
CVS Health
Alexa Berk is the Chief Scientific Officer for Real World Evidence (RWE) at CVS Clinical Trial services, driving scientific strategy internally and within the industry as a speaker and thought leader advocating for patient-centric and methodologically sound scientific methods in RWE and innovative clinical trial design. She has worked in health research for over 20 years, including health outcomes research design and management positions at Memorial Sloan-Kettering Cancer Center and at top pharmaceutical and medical device companies, managing large-scale global clinical trials. Most recently she was the Medical Affairs Director for Digital Health and Data at Invitae, a leading medical genetics company.
Associate Consultant I, Physiology and Biomedical Engineering
Mayo Clinic
Dr. Laura Lambert, PhD is an assistant professor, and she is an associate consultant in the departments of Physiology and Biomedical Engineering (PBME), Biochemistry and Molecular Biology (BMB), and Clinical Genomics at Mayo Clinic. Dr. Lambert is the Director of the Transgenic & Genetically Engineered Models Core Facility at the University of Alabama at Birmingham (UAB).
In 2019, her work centered on creating rat and mouse models to study genetic diseases, including neurofibromatosis (NF). UAB has emerged as an international leader in NF research—their Medical Genomics Lab conducted the greatest number of NF genetic tests in the world.
Coming Soon.
Associate Professor of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and
Science
Associate Consultant II, Biochemistry
Mayo Clinic
Dr. Karl Clark is an associate consultant in biochemistry, and an associate professor of biochemistry and molecular biology. He received his PhD in Molecular, Cellular, Developmental Biology, and Genetics from the University of Minnesota.
The Behavioral and Functional Genetics Lab of Karl J. Clark, Ph.D., focuses on the development of genome engineering tools to interrogate the genetics of stress response and characterize patients' variant alleles that potentially contribute to a wide range of rare disorders. Dr. Clark's lab has four actively funded research projects and welcomes students to participate directly in these projects or to develop related projects that would blossom within the lab's rich workspace.
Dr. Clark's Behavioral and Functional Genetics laboratory contributes to the development of tools and research that aid in the better understanding of how the stress response system develops, how stress signaling impacts patients, and how defects in the mitochondrial genome might be corrected and help identify variants that may contribute to rare disorders.
Associate Professor of BioMedical Informatics, Mayo Clinic College of Medicine
Consultant, Associate Chair of Academic Affairs and Faculty development, Dept. of Quantitative
health Sciences
Co-director, Bioinformatics/Biostatistics and Data Management Cores, Multiple Myeloma SPORE
Co-director, Bioinformatics/Biostatistics Core, Alzheimer's Disease Multi-Center U19
Mayo Clinic
Dr. Yan Asmann is an Associate Professor of Biomedical Informatics, she is co-director of Bioinformatics and Data Management Cores, Multiple Myeloma SPORE and Bioinformatics Core, Alzheimer's Disease Multi-Center U19. She is also a consultant and Associate Chair of Academic Affairs and Faculty development in the department of Quantitative health Sciences at Mayo Clinic.
The research of Dr. Asmann focuses on developing analytical algorithms and frameworks for multi-omics data mining, modeling and integration. Dr. Asmann has applied these methods to study complex disorders and to identify diagnostic-prognostic biomarkers and therapeutic targets. Dr. Asmann collaborates with clinical investigators and laboratory scientists in translational research of several diseases, including women's cancers, multiple myeloma and Alzheimer's disease.
Her focus areas include:
Dr. Asmann's research will enable the discovery, validation and clinical application of genomic biomarkers and therapeutic targets in the era of individualized medicine.
Assistant Professor of Pharmacology and Psychiatry, Mayo Clinic College of Medicine and Science
Senior Associate Consultant I, Molecular Pharmacology and Experimental Therapeutics
Mayo Clinic
Dr. Arjun Athreya is a principal data scientist, associate consultant in the Department of Molecular Pharmacology and Experimental Therapeutics, and assistant professor of pharmacology in the Mayo Clinic College of Medicine.
Dr. Athreya is a leader and expert in developing technologies in artificial intelligence and machine learning. His research and technologies dramatically minimize guessing in the try and try again practice of treating patients by using artificial intelligence and high volumes of patient data to optimize treatment selection and treatment management specific to the patient. This augments physicians’ decision-making abilities, decreasing the risk of treatment failures that bring added disease burden to patients.
Dr. Athreya received his Doctor of Philosophy in computer engineering from the University of Illinois at Urbana-Champaign. Later, he became a research fellow at Mayo Clinic, where he collaborated to build learning methods and models for analyzing clinical data.
Associate Professor of Medicine, Mayo Clinic College of Medicine and Science
Consultant, Gastroenterology and Hepatology
Dr. Yan Bi is an associate professor of medicine and consultant of the Division of Gastroenterology and Hepatology at Mayo Clinic Florida. Dr. Bi has research interests in acute pancreatitis animal models, using artificial intelligence and whereby device for early detection of pancreatic cancer, pancreatic cancer biomarkers. She has a focus on pancreas physiology, pancreatitis, and pancreatic cancer. For early pancreatic cancer detection, Dr. Bi is collaborating with the PRECEDE consortium, which aims to improve early pancreatic cancer detection using artificial intelligence and digital wearable devices for at-risk patients to assist in pancreatic cancer screening and surveillance.
Associate Professor of Surgery and Assistant Professor of Biophysics, Mayo Clinic College of Medicine
and Science
Associate Director, Microbiome Program, Center for Individualized Medicine
Senior Associate Consultant II, Laboratory Medicine and Pathology
Mayo Clinic
Dr. Nicholas Chia is the associate director in the Center for Individualized Medicine Microbiome Program and with surgery researchers as part of a strategic alliance with university partners to combine bioinformatics and ecological and evolutionary theory with medicine.
Many problems in microbiology can be insightfully approached from the viewpoint of systems biology. The interface between evolution and systems biology delivers broader notions of how biological evolution operates on metabolic, protein-protein and regulatory networks. This research expands the understanding of future limits and challenges to treat complex diseases, such as cancer or gastrointestinal disorders.
His research is significant to patient care because colorectal cancer is both common and lethal, and it has plausible connections to several microbial agents. If the hypotheses of Dr. Chia and his team are proven correct, identifying microbiomes that cause cancer and finding ways to quantify that risk could be accomplished using a combination of modern computing and sequencing techniques. Manipulating the gut microbiome using antibiotics, probiotics or prebiotics will help attenuate that risk. This would radically change the way colon cancer is treated.
Professor of Plastic Surgery, Mayo Clinic College of Medicine and Science
Consultant, Plastic and Reconstructive Surgery
Mayo Clinic
Dr. Antonio Forte is a professor and consultant in the Division of Plastic Surgery, Department of Surgery at Mayo Clinic in Florida, with joint appointments in the Department of Neurosurgery and Department of Orthopedic Surgery. Dr. Forte serves as vice chair of Research and Innovation in the Department of Surgery and as medical director of Customer Engagement and Support and medical director of Care Guidance, Consumer Digital Products in the Center for Digital Health. He also serves as the Terrance D. and Judith A. Paul Director of MayoExpert.
Dr. Forte is one of the principal investigators in the High Dimensional Phenotyping Laboratory, a skunkworks laboratory focused on leveraging continuous monitoring data from wearables and touchless sensors to identify digital fingerprint for pain and diseases.
Coming Soon.
Associate Professor of Oncology, Mayo Clinic College of Medicine and Science
Chair of Practice Innovation and Platform
Consultant, Medical Oncology
Mayo Clinic
Dr. Tufia Haddad is a medical oncologist, with specialty interest in precision medicine in breast cancer. She is the Chair of Practice Innovation and Platform, Mayo Clinic Comprehensive Cancer Center, and Medical Director of Care at Home, Center for Digital Health.
Dr. Haddad has a clinical and research interest in breast cancer. Her research focuses on experimental therapeutics and early-phase clinical trials for drug-resistant breast cancer. She is also interested in models of health care delivery in oncology and the transformation of such models with novel artificial intelligence and connected health technology solutions.
Her focus areas include development and conduct of phase I and II clinical trials, development of an independent clinical and translational research program for novel breast cancer therapeutics, evaluation of new targeted treatments for drug-resistant breast cancer, and transformation of breast cancer survivor care with technology-enabled solutions.
Through her partnership with basic scientists, Dr. Haddad helps bring the most promising drugs from lab to clinic and aims to identify biomarkers for these agents to more rapidly advance drug development.
Senior Associate Consultant II, Artificial Intelligence and Informatics
Mayo Clinic
Dr. Tae Hyun Hwang is a senior associate consultant and professor in Artificial Intelligence and Informatics. Dr. Hwang’s research interests are in developing novel machine learning and AI algorithms to ultimately help patients with lethal diseases. One of his roles at Mayo Clinic is to build an internationally recognized program in AI in Oncology.
Dr. Hwang served as a bioinformatics core director for NASA Specialized Centers of Research (NSCOR) to identify biological markers for susceptibility to cancer and early disease detection and countermeasures to reduce risk from exposure to space radiation. He also served as a Data Analysis Core co-director to lead a team of bioinformatician for University of Texas Southwestern Kidney Cancer Specialized Programs of Research Excellence (SPORE) and led a bioinformatics team for University of Texas Lung Cancer SPORE grants.
Dr. Hwang’s is also has research interests in developing machine learning, data mining, bioinformatics methodology to identify prognostic and predictive biomarkers and building predictive models for clinical outcome prediction and treatment stratification. He is currently leading translational machine learning and AI research for precision oncology, immuno-oncology, and cellular therapy in cancer at Mayo Clinic.
Professor of Medicine, Mayo Clinic College of Medicine and Science
Consultant, Gastroenterology and Hepatology
Mayo Clinic
Dr. Prasad Iyer is a consultant in the division of Gastroenterology and Hepatology in the Department of Internal Medicine and a professor of Medicine at Mayo Clinic.
The research program of Dr. Iyer is focused on identifying the most acceptable noninvasive and accurate techniques for the early detection of esophageal neoplasia (precancerous conditions and early cancer) arising in Barrett's esophagus, which is a complication of gastroesophageal reflux, in the population.
Dr. Iyer and his team are studying biomarkers that can help in the early detection and risk assessment of subjects with Barrett's esophagus. His research program is also studying the role of obesity in the development and progression of neoplasia in subjects with Barrett's esophagus.
Research by Dr. Iyer and his colleagues will hopefully improve the outcomes of patients with this lethal malignancy by developing methods to detect disease early, understand how obesity increases cancer risk, and also treat esophageal cancer detected at an early stage by noninvasive, safe endoscopic techniques.
Emeritus Andrew C. Novick Distinguished Professor and Chair of the Glickman Urological and Kidney
Institute and Lerner College of Medicine of the Cleveland Clinic
Distinguished Scientist I, GRAIL Inc.
Eric A. Klein is the Emeritus Andrew C. Novick Distinguished Professor and Chair of the Glickman Urological and Kidney Institute and Lerner College of Medicine of the Cleveland Clinic. He joined the staff of the Cleveland Clinic in 1989 and served as a member of the Department of Cancer Biology of the Cleveland Clinic Lerner Research Institute, the Taussig Cancer Institute, and the Genitourinary Malignancies Program in the Case Comprehensive Cancer Center. Dr. Klein is currently a Fellow in the Distinguished Careers Institute at Stanford University.
Dr. Klein’s clinical and research interests cover all stages of prostate cancer with a focus on genomics and clinical trials. Most recently his work has focused on the clinical development of multicancer early detection tests based on analysis of liquid biopsies using next generation sequencing. Dr. Klein joined GRAIL, Inc as a Distinguished Scientist in 2023.
Assistant Professor of Medicine, Mayo Clinic College of Medicine and Science
Principal Research Technologist, RS-Hematology Research
Dr. Terra Lasho is a myeloid biologist and the chief scientist for the chronic myeloid malignancy (CMD) research group at Mayo Clinic. She mainly investigates Internal medicine, Myelofibrosis, Cancer research, Oncology and Chronic myelomonocytic leukemia. Her Internal medicine study frequently links to related topics such as Gastroenterology. Her Myelofibrosis research is multidisciplinary, relying on both Essential thrombocythemia, Polycythemia vera, Prognostic models and Transplantation.
Her studies deal with areas such as Haematopoiesis, Myeloproliferative neoplasm, Mutant and Somatic cell as well as Cancer research. Her Oncology research is multidisciplinary, incorporating elements of Young adult, Myelodysplastic syndromes and Myeloid. Bone marrow and Immunology are closely tied to her Chronic myelomonocytic leukemia research.
Dr. Lasho’s work has helped to define modern prognostic working models for this group of diseases. In addition, she has developed and implemented the clonal hematopoiesis research NGS panel which is currently used by the Center for Individualized Medicine (CIM) sponsored Mayo Pre-Myeloid and Bone Marrow Failure Clinic.
Founder & CEO, Cholangiocarcinoma Foundation
Stacie Lindsey is the Founder and Chief Executive Officer of the Cholangiocarcinoma Foundation (CCF). Established in 2006, CCF’s mission is to find a cure and improve the quality of life for those affected by cholangiocarcinoma (bile duct cancer) through advocacy, education, collaboration, and research.
Stacie regularly engages with patients, caregivers, and advocates, members of the scientific, medical, and academic communities, policymakers and regulators, and industry and corporate entities to advance and increase scientific research to benefit patients with cholangiocarcinoma. She is a patient advocate on the Mayo Clinic and MGH Hepatobiliary SPOREs and the PE-CGS.
Associate Professor of Medicine, Mayo Clinic College of Medicine and Science
Consultant, Medical Oncology
Mayo Clinic
Dr. Yanyan Lou has earned a reputation as an innovative medical oncologist, helping advance the treatment of lung cancer, pleural mesothelioma and other thoracic diseases through novel immunotherapy and the latest translational research. She is an associate professor at the Mayo Clinic College of Medicine and Science and also serves as the associate director of the Early Cancer Therapeutics Program at Mayo where she plays an active role in the Head and Neck Cancer and Lung Cancer programs.
As part of the acclaimed multidisciplinary treatment program at the Mayo Clinic, Dr. Lou works closely with specialists such as surgeons, pathologists and radiologists to ensure a personalized treatment regimen for each patient. She has done extensive research into the effectiveness of the immunotherapy drug pembrolizumab, also known by the brand name Keytruda, which has been approved by the FDA for treating several cancers, including certain types of mesothelioma.
Director of Clinical Products
OneOme
Dr. Helena Soares is the Director of Clinical Products at OneOme where she oversees all aspects of product operations and development of the RightMed® test, from the user experience to clinical content, and product delivery. She has over 15 years of experience working on scientific and clinical research and product development in the healthcare space, having worked in a variety of environments, from small academic labs to large healthcare institutions, both in the nonprofit and the for-profit space.
Assistant Professor of Family Medicine, Mayo Clinic College of Medicine and Science Department Chair
and Consultant, Family Medicine
Mayo Clinic
Dr. Presutti is an Assistant Professor, the Chair of the Department of Family Medicine for Mayo Clinic Florida, and a Co-Director of Genomics in Action for Mayo Clinic Center for Individualized Medicine. He has served in numerous leadership positions at Mayo Clinic to include Associate Dean of Mayo School of Continuous Professional Development, Medical Director of the Referring Physicians Office, CEO of Mayo Clinic Health System Waycross and President of the Officers and Councilors of the Staff. In these roles he has managed practice transformation with new models of care. Dr. Presutti has also served as the Medical Director for Contracting and Payer Relations for Mayo Clinic. It was during his time with Contracting that he developed an interest in how genomics would transform medicine; he presented to national groups regarding healthcare reform and genomics. His passion is to integrate the use of Family History and machine learning to identify those patients at risk for inherited cancers and how we translate and implement genomic discoveries into the everyday activities of primary care. He is the Florida Principal Investigator for the Tapestry DNA Sequencing Research Study, which is designed to understand the short-term and long-term impact of genetic testing on people's health care when their DNA results are part of the electronic health record.
Assistant Professor, Department of Radiology
Emory University School of Medicine
Dr. Judy Wawira Gichoya is Assistant Professor in the Department of Radiology and Imaging Sciences at Emory University School of Medicine. Dr. Gichoya is a multidisciplinary researcher, trained as both an informatician and an Interventional radiologist.
Drawing upon extensive experience with open source communities and contextual knowledge in Africa, she hopes to leverage her skills to build capacity for data science in Africa.
Dr. Gichoya’s research interests include studying clinical disparities for minimally invasive procedures, validating machine learning models for health in real clinical settings, exploring explainability, fairness, and a specific focus on how algorithms fail. She has worked on the curation of datasets for the SIIM (Society for Imaging Informatics in Medicine) hackathon and ML committee. She volunteers on the ACR and RSNA machine learning committees to support the AI ecosystem to advance development and use of AI in medicine.
Assistant Professor of Medicine, Mayo Clinic College of Medicine and Science
Senior Associate Consultant, Endocrinology, Diabetes and Metabolism
Mayo Clinic
Dr. Jessica Wilson is an Assistant Professor of Medicine and Senior Associate Consultant at Mayo Clinic Florida. She retains an adjunct position at the University of Pennsylvania to facilitate ongoing research collaborations. She completed her physician scientist track fellowship in Endocrinology at Vanderbilt University including obtaining a Master of Science in Clinical Investigation. She has an NIH K23 award from NHLBI entitled “Cardiometabolic Effects of Genetically Decreased Dipeptidyl Peptidase-4 (DPP4)”. Dr. Wilson joined Mayo Clinic Florida in the latter half of 2021 and since then has joined the Steering Committee for CIM, leads PRaUD (program for Rare and Undiagnosed Disease) MODY efforts, is co-chair of the Pancreas Transplant Board, and leads Inpatient Diabetes Quality Improvement initiatives.
Craig-Weaver Professor of Pediatrics, Professor of Health Policy, and
Co-Founder of the Center
for Biomedical Ethics and Society, Vanderbilt University Medical Center
Professor of Law, Vanderbilt Law School
Dr. Ellen Wright Clayton is the Craig-Weaver Professor of Pediatrics, Professor of Health Policy, and Co-Founder of the Center for Biomedical Ethics and Society at Vanderbilt University Medical Center (VUMC) and Professor of Law at the Vanderbilt Law School. Her work is truly transdisciplinary, combining empirical, normative, and legal analytic methods to address real-world challenges. An internationally respected scholar, she has focused for many years on ethical, legal, and social issues presented by conducting research in genetics and genomics and the impact of translating these advances in clinical care and the broader society. She is currently co-PI of VUMC’s highly transdisciplinary Center of Excellence in ELSI Research on genomic privacy and identity, GetPreCiSe, as well as being deeply engaged in the eMERGE consortium since its inception and working as part of both AIM-AHEAD and Bridge2AI to ensure the ethical and legal development and deployment of machine learning and artificial intelligence. She is an elected member of the National Academy of Medicine, where she has served on 11 consensus committees and the Executive Committee and is currently Co-Chair of Report Review.
Senior Computational Scientist
Argonne National Laboratory
Dr. Yitan Zhu is a senior computational scientist in the Data Science and Learning Division at the Argonne National Laboratory. His research interests include machine learning, deep learning, cancer genomics, drug discovery, and medical informatics. Before joining the Argonne National Laboratory, Dr. Zhu worked in pharmaceutical industry and hospital organization. For the past more than fifteen years, Dr. Zhu has been working on developing machine learning and statistical methods to integrate and analyze biomedical data for disease research and therapeutics development.
Cecilia and Dan Carmichael Family Associate Director for the Center for Individualized Medicine in
Florida,
Mayo Clinic
Professor of Psychiatry, Mayo Clinic College of Medicine and Science
Consultant, Psychiatry and Psychology
Mayo Clinic
Dr. William Bobo is the Cecilia and Dan Carmichael Family Associate Director for the Center for Individualized Medicine in Florida. He is also a professor and consultant in Psychiatry and Psychology.
The research interests of Dr. Bobo are focused on examining and predicting the clinical effects — both beneficial and harmful — of medications used to treat people with severe mood disorders. Dr. Bobo's research examines the effects of selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) on vulnerable populations such as pregnant women, and applies artificial intelligence and other advanced computational approaches to health care.
Associate Director for Education, Center for Individualized Medicine, Mayo Clinic in Florida
Associate Professor of Medicine, Gastroenterology and Hepatology
Consultant, Gastroenterology and Hepatology
Associate Dean, School of Continuous Professional Development
Mayo Clinic
Dr. William Palmer actively performs clinical research in iron overload disorders (hereditary hemochromatosis). He serves as medical director for the Hereditary Hemochromatosis Clinic at Mayo Clinic's campus in Florida, which evaluates and treats patients from all over the world with iron overload disorders by employing a state-of-the-art multidisciplinary team of specialists and cutting-edge diagnostics. Dr. Palmer manages a large clinical iron overload database to conduct research. Dr. Palmer also participates in research focused on gastrointestinal endoscopy, patient-provider education, and other chronic liver diseases.
Dr. Palmer's research goals have direct impact on patient care. Improving patient health through education, limiting invasive and costly procedures, and more effectively identifying patients with preventable complications remain his aspirations. Genetic iron overload is a common disease in certain demographics, and focused research goals in this area are paramount to improving patient health.
Professor of Medicine and Cancer Biology
Consultant, Gastroenterology and Hepatology and Transplant Hepatology
Mayo Clinic
Dr. Patel is a consultant in the Department of Transplantation, with joint appointments in the Department of Cancer Biology and the Department of Physiology and Biomedical Engineering.
Dr. Patel’s clinical expertise is in transplant hepatology and hepatobiliary cancers. He is particularly interested in the roles of extracellular vesicles and extracellular RNA in fundamental processes involved in liver cancers. In conjunction with the Extracellular RNA Communication Consortium, funded by the National Institutes of Health (NIH) Common Fund, Dr. Patel and his group are exploring novel biomarkers. Based on this research, they are developing new treatments and exploring new paradigms of disease.
Host Morning Edition, MPR News
Cathy Wurzer is the host of Morning Edition for MPR News. She is also the co-host of Almanac, a weekly public affairs program for which she has won four Emmy Awards. Wurzer also started a new radio show last year titled “Minnesota Now.”
Prior to MPR News, she was an anchor and reporter for WCCO-TV and a talk show host for WCCO-AM radio, a producer for KMSP-TV, and political reporter for KSTP-AM radio. Wurzer is the author of “Tales of the Road: Highway 61”.
She received degrees in broadcast journalism and urban studies from the University of Wisconsin-River Falls.
Associate director of the Science & Policy Program, Oncology Center of Excellence
Deputy division director in the agency’s Office of Oncologic Diseases Food and Drug Administration.
Dr. Fashoyin-Aye is a medical oncologist and Deputy Division Director in the Division of Oncology 3 in the Office of Oncologic Diseases, and the Associate Director in the Oncology Center of Excellence at the Food and Drug Administration.
At the FDA, Dr. Fashoyin-Aje has served as clinical reviewer in the Gastrointestinal Malignancies team, and as team leader for the Breast Malignancies, Melanoma and Sarcoma, and Gastrointestinal Malignancies clinical teams. In her current role, she provides scientific and policy guidance and oversight to multidisciplinary teams reviewing drugs and biologics under development for the treatment of solid tumor (GI, sarcoma, melanoma) malignancies. She has also served as the Oncology Center of Excellence (OCE) Scientific Liaison for Cancer Disparities and in this role, has led the OCE’s efforts to improve inclusion of diverse demographic subgroups in clinical trials and participates in several internal and external scientific and policy working groups. Dr. Fashoyin-Aje also serves on the ASCO Health Equity Committee, the AACR Science of Cancer Health Disparities Scientific Program and Scientific Review committees, and the ASCO Cancer Research Committee.
CEO at American Telemedicine Association
Ann Mond Johnson is CEO of the American Telemedicine Association (the ATA), overseeing the only association focused completely on advancing the adoption of telehealth, with a diverse membership including leading healthcare delivery systems, academic institutions, technology solution providers and payers, as well as partner organizations and alliances. Ann is an industry thought leader representing a growing telehealth sector that includes leading healthcare delivery systems, academic institutions, technology solution providers and payers, working to integrate virtual care into a modernized, two-channel or hybrid care delivery system.
Under Ann’s direction, the ATA is focused on federal and state policy initiatives needed to ensure permanent access to telehealth services, as well as advancing a framework to address disparities using telehealth that will be broadly applicable across healthcare so that everyone has access to safe, effective, and appropriate care when and where they need it.
As part of her vision to create a broad and inclusive community of telehealth stakeholders, the ATA launched the first-ever Telehealth Awareness Week in 2021, bringing together telehealth champions and supporters from every sector of healthcare to underscore the growing value of telehealth and its critical role in care delivery.
Ann has been a pioneer in healthcare for more than two decades, as both an entrepreneur and executive leader, and has launched and built innovative companies that leverage data, decision support tools and digital apps to make the healthcare experience better for consumers. In 2020, Ann was recognized by Modern Healthcare magazine on their 100 Most Influential list. She was inducted in the Chicago Entrepreneurship Hall of Fame in 2016.
Ralph S. and Beverley E. Caulkins Professor of Cancer Research
Professor of Epidemiology, Mayo
Clinic College of Medicine and Science
Consultant, Quantitative Health Sciences
Mayo Clinic
Dr. Cerhan is a professor of epidemiology in the Mayo Clinic College of Medicine and Science, and the Ralph S. and Beverly Caulkins Professor of Cancer Research. He is also co-leader Enterprise Deputy Director, Population Science and Cancer Control in the Mayo Clinic Comprehensive Cancer Center, co-director of the Biorepositories Program in the Mayo Clinic Center for Individualized Medicine and associate director of the Mayo Clinic Cancer Registry.
The main research focus of Dr. Cerhan is using epidemiologic approaches to study the causes and outcomes of cancer in human populations. Identifying the causes of lymphoma and other cancers allows for new approaches to risk stratification and prevention. Examining the ways lymphoma patients are impacted over time leads to improved outcomes and survivorship. Furthermore, building and sustaining a robust infrastructure for human research lowers the cost to patients and families and speeds up translating discoveries, both now and in the future.
Dr. Cerhan’s main research focus areas are:
Coming Soon.
Chief Growth Officer
Medable
Sanskriti (Sans) Thakur serves the life sciences industry with executive experience across scientific development, corporate and commercial strategy, with early stage digital and medical technology management. Sans is currently the Chief Growth Officer for Medable, the leading technology platform for clinical development. She is focused on corporate growth to advance the company’s vision of human-centered research, enabling remote access to clinical trials regardless of geography, income, and race. In her journey with Medable she has helped the company grow over 300%.
Beyond her professional titles, she serves with the Global Future Council of the World Economic Forum focusing on data and innovations in healthcare. Sans is a thought leader in issues ranging from modern healthcare, women’s health, clinical trials, to patient advocacy. She is the author of over 18 publications in the areas of science, business and technology intersections.
Before Medable, Sans served as head of global life sciences research for Accenture, responsible for market-shaping strategy and research in therapeutics, digital health, and business model innovation across Accenture’s multi-billion dollar life science enterprise.
Over the last 20 years in the life sciences industry, Sans has advised more than 30 companies, launched 10 products, advised digital health venture funds, and managed a leading pharmaceutical portfolio.